LSE - Delayed Quote GBp
ImmuPharma plc (IMM.L)
3.1200
-0.0150
(-0.48%)
At close: May 7 at 5:09:12 PM GMT+1
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-1,364.4070
-1,364.4070
-2,347.0650
-4,833.1720
-3,329.4010
Investing Cash Flow
188.7620
188.7620
-77.4240
-50.2830
-569.2010
Financing Cash Flow
722.0960
722.0960
1,547.7300
702.0470
8,370.3540
End Cash Position
208.4810
208.4810
667.8130
1,649.3740
5,862.0570
Capital Expenditure
--
--
-106.0090
-50.9340
-360.2900
Issuance of Capital Stock
1,480.6830
1,480.6830
2,350.9090
3,550
8,000
Issuance of Debt
--
--
--
0
2,152.2520
Repayment of Debt
--
--
0
-722.9780
-836.6060
Free Cash Flow
-1,364.4070
-1,364.4070
-2,453.0740
-4,884.1060
-3,689.6910
12/31/2020 - 10/28/2003
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
OPTI.L OptiBiotix Health Plc
19.25
-6.10%
BT1.BE Bone Therapeutics SA
0.0016
+6.67%
CIZ.L Cizzle Biotechnology Holdings Plc
1.5000
-3.23%
VAL.L ValiRx plc
0.5500
0.00%
2157.HK Lepu Biopharma Co., Ltd.
5.350
+14.81%
SCLP.L Scancell Holdings plc
9.75
-2.99%
TRX.L Tissue Regenix Group plc
32.50
0.00%
POLB.L Poolbeg Pharma PLC
3.0000
-0.83%
ALCLS.PA Cellectis S.A.
1.4040
-6.65%
BVXP.L Bioventix PLC
2,750.00
-2.48%